[Hypertensive cardiopathy--an adaptive or a pathologic phenomenon?].

Area of Science:

• Cardiology
• Pathophysiology
• Hypertension Research

Context:

• Hypertensive cardiopathy, defined as left ventricular hypertrophy secondary to sustained hypertension, presents complex physiopathological mechanisms and clinical manifestations.
• It is associated with all severities of arterial hypertension, not just severe forms.
• Understanding its progression is crucial for managing cardiovascular health.

Purpose:

• To elucidate the physiopathological mechanisms and clinical aspects of hypertensive cardiopathy.
• To highlight the role of increased parietal tension as the primary initiator of myocardial hypertrophy.
• To detail the progressive nature of hypertensive cardiopathy, from adaptive to pathological hypertrophy, affecting cardiac function.

Summary:

• Increased parietal tension (hemodynamic hypertrophy) is identified as the main factor initiating myocardial hypertrophy in hypertensive cardiopathy.
• The condition evolves progressively, with initially adaptive hypertrophy becoming pathological, impairing diastolic and then systolic cardiac function, potentially leading to congestive cardiac insufficiency.
• Echocardiography is presented as the most accurate method for quantifying hypertrophy, assessing cardiac performance, and identifying characteristic features of hypertensive cardiopathy.

Impact:

• Provides a clearer understanding of hypertensive cardiopathy's progression and underlying mechanisms.
• Emphasizes echocardiography's critical role in diagnosis and management.
• Establishes hypertensive hypertrophy as a significant supplementary cardiovascular risk factor, underscoring the need for early detection and intervention.